The significance of D-dimer investigation in Iraqi children with COVID-19

Cross sectional study

https://doi.org/10.53730/ijhs.v6nS1.8210

Authors

  • Raed Khudhair Farhan M.B.Ch.B./ F.I.C.M.S./Pediatrician/ Children and Maternity Teaching Hospital/ Department of Pediatrics/ Al-Diwaniyah Province/ Iraq
  • Ahmed Jawad Kadhim Al Abdullah M.B.Ch.B./ F.I.C.M.S./Pediatrician/ Afak Hospital/ Department of Pediatrics/ Al-Diwaniyah Province/ Iraq
  • Mundher Abdzaid Shamhood M.B.Ch.B./ F.I.C.M.S./Pediatrician/ Al-Hamza Hospital/ Department of Pediatrics/ Al-Diwaniyah Province/ Iraq

Keywords:

D-dimer, Iraqi Children, COVID-19

Abstract

Background: The proportion of children affected with COVID-19 accounted for approximately 1 to 2 % of all infected cases and the disease often follows a mild to moderate disease. Increased coagulation and events that are thrombotic were repeatedly recorded in adult patients with COVID-19. Nevertheless, till now, there is no consensus about thrombotic events in children in published articles. Aim of the study: to make evaluation of d-dimer level in children with COVID-19 and the rate of thrombotic complications. Patients and methods: The present research that is of cross sectional type was carried out in Children and Maternity Teaching Hospital in Al-Diwaniyah Province, Iraq. The study included 168 children with COVDI-19 proved by positive RT-PCR results following nasopharyngeal swabs. The age ranged from one month up to 15 years and the study included 77 girls and 91 boys. Results: The current study included 168 children affected by COVID-9. The median level of d-dimer in those enrolled children was 0.3 µg/ml with a range of 0.05 to 11 µg/ml. According to a cutoff value of > 0.05 µg/ml, children were categorized into 73 (43.5 %) cases as having high d-dimer level and 95 (56.5 %) as having normal d-dimer level.

Downloads

Download data is not yet available.

References

Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy. 2020;5:6.

Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-154.

Zaffanello M, Piacentini G, Nosetti L, Ganzarolli S, Franchini M. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature. Thromb Res. 2021;205:92-98.

Rabinowicz S, Leshem E, Pessach IM. COVID-19 in the Pediatric Population-Review and Current Evidence. Curr Infect Dis Rep. 2020;22(11):29.

Götzinger F, Santiago-garcía B, Noguera-julián A, Lanaspa M, Lancella L, Carducci FIC. Articles COVID-19 in children and adolescents in Europe : a multinational , multicentre cohort study. 2020;4642:1–9.

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145.

Rathore V, Galhotra A, Pal R, Sahu KK. COVID-19 Pandemic and Children: A Review. J Pediatr Pharmacol Ther. 2020;25(7):574-585.

Mann JA, Bird PW, Bandi S, Tang JW. Asymptomatic SARS-CoV-2-infected children attending hospital with non-COVID-19 diagnoses, March 2020-February 2021. J Infect. 2021;83(2):237-279.

Bhopal SS, Bagaria J, Olabi B, Bhopal R. COVID-19 deaths in children: comparison with all- and other causes and trends in incidence of mortality. Public Health. 2020;188:32-34.

Shibeeb S, Ahmad MN. Thrombotic and Hypercoagulability Complications of COVID-19: An Update. J Blood Med. 2021;12:785-793.

Bhaskar S., Sinha A., Banach M., Mittoo S., Weissert R., Kass J.S., Rajagopal S., Pai A.R., Kutty S. Cytokine storm in COVID-19—immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper. Front. Immunol. 2020;11

Fogarty H., Townsend L., Ni Cheallaigh C., Bergin C., Martin-Loeches I., Browne P., Bacon C.L., Gaule R., Gillett A., Byrne M., Ryan K., O’Connell N., O’Sullivan J.M., Conlon N., O’Donnell J.S. COVID19 coagulopathy in caucasian patients. Br. J. Haematol. 2020;189:1044–1049.

Lu Y.Feng, Pan L.Ya, Zhang W.W., Cheng F., Hu S.S., Zhang X., Jiang H.Yin. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int. J. Infect. Dis. 2020;100:34–41.

Lippi G., Sanchis-Gomar F., Favaloro E.J., Lavie C.J., Henry B.M. Coronavirus disease 2019-associated coagulopathy. Mayo Clin. Proc. 2021;96:203–217.

Rothan H.A., Byrareddy S.N. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic. Pediatr. Allergy Immunol. 2020

Jiang L., Tang K., Levin M., Irfan O., Morris S.K., Wilson K., Klein J.D., Bhutta Z.A. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect. Dis. 2020;20:e276–e288.

Favresse J, Lippi G, Roy PM, Chatelain B, Jacqmin H, Ten Cate H, Mullier F. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications. Crit Rev Clin Lab Sci. 2018 Dec;55(8):548-577.

Ghazanfar MN, Thomsen SF. D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. Eur J Dermatol. 2018 Dec 01;28(6):731-735.

Franchini M., Marano G., Cruciani M., Mengoli C., Pati I., Masiello F., Veropalumbo E., Pupella S., Vaglio S., Liumbruno G.M. COVID-19-associated coagulopathy. Diagnosis. 2020;7:357–363. doi: 10.1515/dx-2020-0078.

Malas M.B., Naazie I.N., Elsayed N., Mathlouthi A., Marmor R., Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine. 2020;29–30

Zaffanello M., Piacentini G., Nosetti L., Franchini M. The use of convalescent plasma for pediatric patients with SARS-CoV-2: a systematic literature review. Transfus. Apher. Sci. 2021

She J., Liu L., Liu W. COVID-19 epidemic: disease characteristics in children. J. Med. Virol. 2020;92:747–754

Duarte-Salles T., Vizcaya D., Pistillo A., Casajust P., Sena A.G., Lai L.Y.H., Prats-Uribe A., Ahmed W.U., Alshammari T.M., Alghoul H., Alser O., Burn E., You S.C., Areia C., Blacketer C., DuVall S., Falconer T., Fernandez-Bertolin S., Fortin S., Golozar A., Gong M., Tan E.H., Huser V., Iveli P., Morales D.R., Nyberg F., Posada J.D., Recalde M., Roel E., Schilling L.M., Shah N.H., Shah K., Suchard M.A., Zhang L., Williams A.E., Reich C.G., Kostka K., Prieto-Alhambra D. Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study. MedRxiv Prepr. Serv. Heal. Sci. 2020

Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–1608.

Hoang A., Chorath K., Moreira A., Evans M., Burmeister-Morton F., Burmeister F., Naqvi R., Petershack M., Moreira A. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine. 2020;24

Mitchell W.B. Thromboinflammation in COVID-19 acute lung injury. Paediatr. Respir. Rev. 2020;35:20–24.

Goldenberg N.A., Sochet A., Albisetti M., Biss T., Bonduel M., Jaffray J., MacLaren G., Monagle P., O’Brien S., Raffini L., Revel-Vilk S., Sirachainan N., Williams S., Zia A., Male C. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19–related illness. J. Thromb. Haemost. 2020;18:3099–3105.

Boban M. Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. Int. J. Clin. Pract. 2020

Del Borrello G., Giraudo I., Bondone C., Denina M., Garazzino S., Linari C., Mignone F., Pruccoli G., Scolfaro C., Spadea M., Pollio B., Saracco P. SARS-COV-2–associated coagulopathy and thromboembolism prophylaxis in children: a single-center observational study. J. Thromb. Haemost. 2020

Diorio C., Henrickson S.E., Vella L.A., McNerney K.O., Chase J., Burudpakdee C., Lee J.H., Jasen C., Balamuth F., Barrett D.M., Banwell B.L., Bernt K.M., Blatz A.M., Chiotos K., Fisher B.T., Fitzgerald J.C., Gerber J.S., Gollomp K., Gray C., Grupp S.A., Harris R.M., Kilbaugh T.J., Odom John A.R., Lambert M., Liebling E.J., Paessler M.E., Petrosa W., Phillips C., Reilly A.F., Romberg N.D., Seif A., Sesok-Pizzini D.A., Sullivan K.E., Vardaro J., Behrens E.M., Teachey D.T., Bassiri H. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2. J. Clin. Invest. 2020;130:5967–5975.

Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., Barranco M.A., Maxted A.M., Rosenberg E.S., Easton D., Udo T., Kumar J., Pulver W., Smith L., Hutton B., Blog D., Zucker H. Multisystem inflammatory syndrome in children in New York state. N. Engl. J. Med. 2020;383:347–358.

Minocha P.K., Phoon C.K.L., Verma S., Singh R.K. Cardiac findings in pediatric patients with multisystem inflammatory syndrome in children associated with COVID-19. Clin. Pediatr. (Phila) 2021;60:119–126.

Henderson L.A., Friedman K.G., Kernan K.F., Canna S.W., Gorelik M., Lapidus S.K., Bassiri H., Behrens E.M., Ferris A., Schulert G.S., Seo P., Son M.B.F., Tremoulet A.H., Yeung R.S.M., Karp D.R., Mehta J.J. Reply to prophylactic anticoagulation: comment on the ACR guidance for management of multisystem inflammatory syndrome in children. Arthritis Rheumatol. (Hoboken, N.J.) 2021

Published

31-05-2022

How to Cite

Farhan, R. K. ., Al Abdullah, A. J. K., & Shamhood, M. A. (2022). The significance of D-dimer investigation in Iraqi children with COVID-19: Cross sectional study. International Journal of Health Sciences, 6(S1), 12881–12888. https://doi.org/10.53730/ijhs.v6nS1.8210

Issue

Section

Peer Review Articles